• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SILK BLK 30IN USP4-0; SUTURE, NONABSORBABLE, SILK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SILK BLK 30IN USP4-0; SUTURE, NONABSORBABLE, SILK Back to Search Results
Model Number K942H
Medical Device Problem Code Material Separation (1562)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/01/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Product complaint # (b)(4).Component code: (b)(4) device not returned.Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested, and the following was obtained: did the patient experience any adverse consequences due to this issue? not reported.Please provide procedure date? unknown.What is the status of the return samples? distributor will return some samples from the same box not used in procedure.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.
 
Event or Problem Description
It was reported that a patient underwent a dental procedure on an unknown date and suture was used.Intra-operatively the needle detached from the suture.No adverse patient consequences were reported.Additional information was requested.
 
Additional Manufacturer Narrative
(b)(4).Date sent to fda: (b)(6)2021.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information: h6 (b)(4).Date sent to fda:(b)(6)2021.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Corrected information: d3.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SILK BLK 30IN USP4-0
Common Device Name
SUTURE, NONABSORBABLE, SILK
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08876
MDR Report Key11363646
Report Number2210968-2021-01656
Device Sequence Number19042007
Product Code GAP
UDI-Device Identifier10705031100770
UDI-Public10705031100770
Combination Product (Y/N)N
Initial Reporter CountryIT
PMA/510(K) Number
K946173
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source distributor,foreign,health pr
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 02/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2024
Device Model NumberK942H
Device Catalogue NumberK942H
Device Lot NumberPBQ793
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/02/2021
Supplement Date Received by Manufacturer05/03/2021
Initial Report FDA Received Date02/22/2021
Supplement Report FDA Received Date05/03/2021
Patient Sequence Number1
-
-